Developmental features of human striatal tissue transplanted in a rat model of Huntington's disease

Neurobiology of Disease

Volumn 3, Issue 4, 1997, Pages 299-311

  Grasbon Frodl, Eva M ^a   Nakao, Naoyuki ^a,b   Lindvall, Olle ^a   Brundin, Patrik ^a  

^a LUND UNIVERSITY   (Sweden)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GRAFT SURVIVAL; HUMAN TISSUE; HUNTINGTON CHOREA; NONHUMAN; PRIORITY JOURNAL; RAT; TARGET CELL; TISSUE GRAFT;

EID: 0030932167     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1996.0124     Document Type: Article

References (44)

1. Azumi N., Battifora H. The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin- and alcohol-fixed tumors. Am. J. Pathol. 88:1987;286-296.
2. Brundin P., Fricker R., Nakao N. Paucity of P-zones in striatal grafts prohibit commencement of clinical trials in Huntington's disease. Neuroscience. 71:1996;895-897.
3. Brundin P., Nilsson O. G., Strecker R. E., Lindvall O., Åstedt B., Björklund A. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp. Brain Res. 39:1986;235-240.
4. Calvo J. L., Carbonell A. L., Boya J. Co-expression of glial fibrillary acidic protein and vimentin in reactive astrocytes following brain injury in rats. Brain Res. 566:1991;333-336.
5. Dahl D., Rueger D. C., Bugnami A., Weber K., Osborn M. Vimentin, the 57,000 molecular weight protein of fibroblast filaments, is the major cytoskeletal component in immature glia. Eur. J. Cell Biol. 24:1981;191-196.
6. Deacon T. W., Pakzaban P., Isacson O. The lateral ganglionic eminence is the origin of cells committed to striatal phenotypes: Neural transplantation and developmental evidence. Brain Res. 668:1994a;211-219.
7. Deacon T. W., Pakzaban P., Burns L. H., Dinsmore J., Isacson O. Cytoarchitectonic development, axon-glia relationships, and long distance axon growth of porcine striatal xenografts in rats. Exp. Neurol. 130:1994b;151-167.
8. Duan W.-M., Widner H., Brundin P. Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic neuronal tissue grafts. Exp. Brain Res. 104:1995;227-242.
9. Franke W. W., Schmid E., Osborne M., Weber K. Different intermediate sized filaments distinguished by immunofluorescence microscopy. Proc. Natl. Acad. Sci. USA. 75:1978;5034-5038.
10. Freeman T. B., Sanberg P. R., Isacson O. Development of the human striatum: Implications for fetal striatal transplantation in the treatment of Huntington's disease. Cell Transplant. 4:1995;539-545.
11. Fricker R. A., Torres E. M., Dunnett S. B. The effects of donor stage on the survival and function of embryonic striatal grafts. I. Morphological characteristics. Neuroscience. 1996a.
12. Fricker R. A., Torres E. M., Hume S. P., Myers R., Opacka-Juffrey J., Ashworth S., Brooks D. J., Dunnett S. B. The effects of donor stage on the survival and function of embryonic striatal grafts. II. Correlation between positron emission tomography and reaching behaviour. Neuroscience. 1996b.
13. Frodl E. M., Duan W. M., Sauer H., Kupsch A., Brundin P. Human embryonic dopamine neurons xenografted to the rat: Effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function. Brain Res. 647:1994;286-298.
14. Geny C., Naimi-Sadaoui S., Jeny R., Belkadi A., Juliano S. L., Peschanski M. Long-term delayed vascularization of human neural transplants to the rat brain. J. Neurosci. 14:1994;7553-7562.
15. Giordana M. T., Attanasio A., Cavalla P., Mighlei A., Vigliani M. C., Schiffer D. Reactive cell proliferation and microglia following injury to the rat brain. Neuropathol. Appl. Neurobiol. 20:1994;163-174.
16. Goslin K., Schreyer D. J., Skene J. H., Banker G. Development of neuronal polarity: GAP-43 distinguishes axonal from dendritic growth cones. Nature. 336:1988;672-674.
17. Graeber M. B., Streit W. J., Kreutzberg G. W. The microglial cytoskeleton: Vimentin is localized within activated cells in situ. J. Neurocytol. 17:1988;573-580.
18. Grasbon-Frodl E. M., Nakao N., Lindvall O., Brundin P. Phenotypic development of the human embryonic striatal primordium: A study of cultured and grafted neurons from the lateral and medial ganglionic eminences. Neuroscience. 73:1996;185-200.
19. Graybiel A. M., Liu F. C., Dunnett S. B. Intrastriatal grafts derived from fetal striatal primordia. I. Phenotypy and modular organization. J. Neurosci. 9:1989;3250-3271.
20. Hedreen J. G., Bacon S. J., Price D. L. A modified histochemical technique to visualize acetylcholinesterase-containing axons. J. Histochem. Cytochem. 33:1985;134-140.
21. Isacson O., Fisher W., Wictorin K., Dawbarn D., Björklund A. Astroglial response in the excitotoxically lesioned neostriatum and its projection areas in the rat. Neuroscience. 20:1987;1043-1056.
22. Janeczko K. Co-expression of GFAP and Vimentin in astrocytes proliferating in response to injury in the mouse cerebral hemisphere. A combined autoradiographic and double immunocytochemical study. Int. J. Dev. Neurosci. 11:1993;139-147.
23. Kanazir S., Ruzdijic S., Vukosavic S., Ivkovic S., Milosevic A., Zecevic N., Rakic L. GAP-43 mRNA expression in early development of human nervous system. Mol. Brain Res. 38:1996;145-155.
24. Kurth M. C., Kopyov O., Jacques D. B. Six month follow-up of motor function after fetal transplantation in a patient with Huntington's disease. Movement Dis. 11:1996;250.
25. Labandeira-Garcia J. L., Wictorin K., Cunningham E. T. Jr, Björklund A. Development of intrastriatal striatal grafts and their afferent innervation from the host. Neuroscience. 42:1991;407-426.
26. Levivier M., Gash D. M., Przedbroski S. Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum. Neuroscience. 69:1995;43-50.
27. Lundberg C., Björklund A. Host regulation of glial markers in intrastriatal grafts of conditionally immortalized neural stem cell lines. Neuroreport. 7:1996;847-852.
28. Meiri K. F., Pfenninger K. H., Willard M. B. Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones. Proc. Natl. Acad. Sci. USA. 83:1986;3537-3541.
29. Meiri K. F., Willard M., Johnson M. I. Distribution and phosphorylation of the growth-associated protein in regenerating sympathetic neurons in culture. J. Neurosci. 8:1988;2571-2581.
30. Milosevic A., Kanazir S., Zecevic N. Immunocytochemical localization of growth-associated protein GAP-43 in early human development. Brain Res. 84:1995;282-286.
31. Naimi S., Jeny R., Hantraye P., Peschanski M., Riche D. Ontogeny of human striatal DARPP-32 neurons in fetuses and following xenografting into the adult brain. Exp. Neurol. 137:1996;15-25.
32. Nakao N., Grasbon-Frodl E. M., Widner H., Brudin P. DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw-reaching in an animal model of Huntington's disease. Neuroscience. 74:1996;959-970.
33. Nakao N., Odin P., Brundin P. Selective subdissection of striatal primordium for cultures affects the yield of DARPP-32-containing neurons. Neuroreport. 5:1994;1081-1084.
34. O'Rahilly R., Müller F. The Embryonic Human Brain. An Atlas of Developmental Stages. 1994;Carnegie Institution of Washington, Washington.
35. O'Rahilly R., Müller F. Developmental Stages of Human Embryos. 1987;Carnegie Institution of Washington, Washington.
36. Olsson M., Campbell K., Wictorin K., Björklund A. Projection neurons in fetal striatal transplants are predominantly derived from the lateral ganglionic eminence. Neuroscience. 69:1995;1169-1182.
37. Pakzaban P., Deacon T. W., Burns L. H., Isacson O. Increased proportion of acetylcholinesterase-rich zones and improved morphological integration in host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence. Exp. Brain Res. 97:1993;13-22.
38. Peschanski M., Cesaro P., Hantraye P. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience. 68:1995;273-285.
39. Pundt L. L., Kondoh T., Conrad J. A., Low W. C. Transplantation of human striatal tissue into a rodent model of Huntington's disease: Phenotypic expression of transplanted neurons and host-to-graft innervation. Brain Res. Bull. 39:1996;23-32.
40. Pundt L. L., Kondoh T., Low W. C. The fate of human glial cells following transplantation in normal rodents and rodent models of neurodegenerative disease. Brain Res. 695:1995;25-36.
41. Schiffer D., Giordana M. T., Cavallam P., Vigliani M. C., Attanasio A. Immunohistochemistry of glial reaction afterinjury in the rat: Double stainings and markers of cell proliferation. Int. J. Dev. Neurosci. 11:1993;269-280.
42. Shannon K. M., Kordower J. H. Neural transplantation for Huntington's disease: Experimental rationale and recommendation for clinical trials. Cell Transplant. 5:1996;339-352.
43. Sirinathsinghji D. J. S., Mayer E., Stam R., Fernandez J. M., Dunnett S. B. The expression of GAP-43 mRNA in developing embryonic striatal tissue grafts. Neuroreport. 4:1993;175-178.
44. Wictorin K., Ouimet C. C., Björklund A. Intrinsic organization and connectivity of intrastriatal striatal transplants in rats as revealed by DARPP-32 immunohistochemistry. Eur. J. Neurosci. 1:1989;690-701.